Ultragenyx Participates in UBS and Jefferies Investor Conferences
Bitget2026/11/11 13:31- Ultragenyx will attend the UBS Global Biopharma Conference in London on Nov. 16, 2026.
- Management will also attend the Jefferies Global Healthcare Conference in London on Nov. 17, 2026.
- Executives will participate in fireside chats and host one-on-one meetings at both events.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic IPO frenzy! Subscription demand several times oversubscribed, targeting a valuation of 1.4 trillions USD
Anthropic's upcoming IPO has sparked strong market enthusiasm, with subscription demand reaching several times the offering. The company plans to raise up to 90.4 billions USD through the IPO and private placement, potentially setting a new record for the largest listing in history. Although its valuation target of 1.4 trillions USD is slightly lower than previously expected, the market response remains extremely enthusiastic, fueled by robust institutional anchor demand.
BUZZ-Satellogic shares surge on strong third-quarter results
Forward Industries Adds 226,396 SOL as Solana Price Falls to $82
Crypto prices
More
